Insider Trading activities of Outlook Therapeutics, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Outlook Therapeutics, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Outlook Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Outlook Therapeutics, Inc. since 2005. The reporting company's ticker symbol is OTLK. The reporting company's CIK number is 1649989.
The total value of stock buying since 2005 is $135,980.
The total value of stock sales since 2005 is $592,893.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Outlook Therapeutics, Inc. (OTLK).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-02 39,183 $33,475 0 $0 0 $0
2019-01 106,548 $72,841 0 $0 0 $0
2018-12 49,416 $29,664 0 $0 0 $0
2018-09 0 $0 10,100 $8,807 0 $0
2018-06 0 $0 7,700 $6,506 0 $0
2018-01 0 $0 114,677 $134,067 0 $0
2017-12 0 $0 195,996 $223,251 0 $0
2016-11 0 $0 58,737 $220,262 405,796 $0
2016-05 2,000 $0 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Outlook Therapeutics, Inc. insiders (OTLK)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-02-07 Kenyon Lawrence A (CEO, Pres, CFO, Treas & Secy) Buy 25,000 .90 22,375
2019-02-04 Hilzinger Kurt J (Director) Buy 5,983 .80 4,786
2019-02-01 Hilzinger Kurt J (Director) Buy 8,200 .77 6,314
2019-01-31 Hilzinger Kurt J (Director) Buy 6,300 .75 4,725
2019-01-30 Hilzinger Kurt J (Director) Buy 4,890 .72 3,520
2019-01-29 Hilzinger Kurt J (Director) Buy 5,400 .73 3,942
2019-01-28 Hilzinger Kurt J (Director) Buy 15,884 .71 11,277
2019-01-25 Hilzinger Kurt J (Director) Buy 10,828 .69 7,471
2019-01-23 Hilzinger Kurt J (Director) Buy 2,266 .67 1,518
2019-01-22 Hilzinger Kurt J (Director) Buy 10,749 .68 7,309
2019-01-17 Hilzinger Kurt J (Director) Buy 2,300 .69 1,586
2019-01-16 Hilzinger Kurt J (Director) Buy 800 .68 544
2019-01-15 Mohan Pankaj (Director) Buy 8,000 .68 5,440
2019-01-15 Hilzinger Kurt J (Director) Buy 2,266 .70 1,586
2019-01-14 Hilzinger Kurt J (Director) Buy 4,399 .71 3,123
2019-01-10 Hilzinger Kurt J (Director) Buy 6,053 .70 4,237
2019-01-09 Hilzinger Kurt J (Director) Buy 2,792 .73 2,038
2019-01-08 Hilzinger Kurt J (Director) Buy 6,410 .65 4,166
2019-01-07 Hilzinger Kurt J (Director) Buy 5,166 .63 3,254
2019-01-04 Hilzinger Kurt J (Director) Buy 6,205 .59 3,660
2019-01-03 Hilzinger Kurt J (Director) Buy 4,200 .59 2,478
2019-01-02 Hilzinger Kurt J (Director) Buy 1,640 .59 967
2018-12-31 Hilzinger Kurt J (Director) Buy 11,349 .59 6,695
2018-12-28 Hilzinger Kurt J (Director) Buy 11,910 .52 6,193
2018-12-27 Hilzinger Kurt J (Director) Buy 730 .51 372
2018-12-26 Hilzinger Kurt J (Director) Buy 5,714 .54 3,085
2018-12-24 Hilzinger Kurt J (Director) Buy 1,113 .66 734
2018-12-21 Thurman Randy H (Director) Buy 15,000 .68 10,245
2018-12-21 Hilzinger Kurt J (Director) Buy 3,600 .65 2,340
2018-09-18 Kenyon Lawrence A (CEO, Pres, CFO, Treas & Secy) Sale 10,100 .87 8,807
2018-06-25 Bahrt Kenneth (Chief Medical Officer) Sale 7,700 .84 6,506
2018-01-04 Mohan Pankaj (President & CEO) Sale 62,569 1.16 72,580
2018-01-03 Mohan Pankaj (President & CEO) Sale 52,108 1.18 61,487
2017-12-22 Yamashita Elizabeth A. (VP, Regulatory Affairs) Sale 16,170 1.13 18,272
2017-12-22 Bahrt Kenneth (Chief Medical Officer) Sale 26,165 1.13 29,566
2017-12-22 Kenyon Lawrence A (CFO and Secretary) Sale 26,165 1.13 29,566
2017-12-22 Mcandrew Stephen J (SVP Bus. Strat. & Dev.) Sale 15,705 1.13 17,746
2017-12-19 Mohan Pankaj (President & CEO) Sale 83,608 1.14 95,313
2017-12-19 Yamashita Elizabeth A. (VP, Regulatory Affairs) Sale 6,151 1.14 7,012
2017-12-18 Mohan Pankaj (President & CEO) Sale 20,523 1.17 24,011
2017-12-18 Yamashita Elizabeth A. (VP, Regulatory Affairs) Sale 1,509 1.17 1,765
2016-11-23 Griffith Donald J. Sale 1 3.75 3
2016-11-11 Gangloff Scott A. (SVP, Development & Mfrg) Sale 37,369 3.75 140,133
2016-11-11 Mcandrew Stephen J (SVP Bus. Strat. & Dev.) Sale 21,367 3.75 80,126
2016-11-09 Gangloff Scott A. (SVP, Development & Mfrg) Option Ex 115,942 .00 0
2016-11-09 Griffith Donald J. Option Ex 144,927 .00 0
2016-11-09 Brady Todd C Option Ex 28,985 .00 0
2016-11-09 Canute Scott A Option Ex 57,971 .00 0
2016-11-09 Mcandrew Stephen J (SVP Bus. Strat. & Dev.) Option Ex 57,971 .00 0
2016-05-13 Bahrt Kenneth (Chief Medical Officer) Buy 2,000 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises of OTLK listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Outlook Therapeutics, Inc. (symbol OTLK, CIK number 1649989) see the Securities and Exchange Commission (SEC) website.